Clinical Trial Update: HID-HSCT Versus IST as First-line Treatment for SAA [NA]

View source ↗

Summary

This clinical trial compares haploidentical hematopoietic stem cell transplantation (HID-HSCT) versus immunosuppressive therapy as first-line treatment for apla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anaemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Aplastic Anaemia | NA | Status: NOT_YET_RECRUITING